Apollon Formularies Plc Result of AGM

 
TIDMAPOL 
 
2 January 2024 
 
Apollon Formularies Plc 
 
Result of AGM 
 
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company") is pleased to 
announce that following the Company's Annual General Meeting held on 29 December 
2023, all resolutions were duly passed. 
 
-ENDS- 
 
For additional information, please visit www.apollon.org.uk or contact: 
 
Apollon Formularies 
 
Tel:                                                      +44 771 198 0221 
 
Stene Jacobs                                      stene@apollon.org.uk 
 
Peterhouse Capital Limited (Corporate Adviser) 
 
Tel:                                                       +44 207 220 9795 
 
Guy Miller                                           gm@peterhousecapital.com 
 
About Apollon Formularies and Apollon Formularies Jamaica 
 
Apollon Formularies plc is an international medical cannabis and medicinal 
mushroom pharmaceutical company headquartered in the United Kingdom. Apollon 
Formularies Jamaica Limited is a pharmaceutical company incorporated and 
operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed 
by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate 
(R&D), perform research and development, process, and sell medical cannabis 
therapeutic products that include legal medical cannabis to treat various 
illnesses under medical supervision. 
 
 
This information was brought to you by Cision http://news.cision.com 
 
 
END

(END) Dow Jones Newswires

January 02, 2024 03:18 ET (08:18 GMT)

Apollon Formularies (AQSE:APOL)
Historical Stock Chart
From Apr 2024 to May 2024